LoginSign up
InsightfulValue
← Home

Coloplast
Coloplast

-5.92%

Healthcare & biotech / Medical devices and services

Founded: 1957 | Country: Denmark | Ticker: CLPBY | Rate: 1000 | DCF: 0.92 | Price: 9.92

At a Glance Core Facts Company Q&A Industry Q&A Competitors Stock Swings News Income Statement Balance Sheet Cash Flow Statement Financial Growth Enterprise Ratios Metrics Dividends Risks SWOT Porter's Five Forces PEST Score Positive Clusters Due Diligence Insider Trades SEC Filings Stock Split History Press Releases Earnings Calendar Revenue Segmentation Owner Earnings Reports Web
The Checklist Value Investor: A Smarter Way to Pick Stocks

Get your free eBook: The Checklist Value Investor — A Smarter Way to Pick Stocks.
📘 Inside, you’ll discover:

  • How to spot high-quality businesses
  • The mindset that beats the market
  • Checklists used by professionals
  • Case studies of both wins and mistakes
  • Avoid common investing traps
  • Decide with logic, not emotion

Sign up for free

and download the eBook instantly!
Already have an account?
Log in here.

Press Releases

Date Press release
2025-02-04 08:27:00 Coloplast Finance B.v. - Interim Financial Report, Q1 2024/25
2024/25 interim financial results, q1 2024/25 1 october 2024 - 31 december 2024 coloplast delivered 8% organic growth and an ebit margin1 of 27% in q1, in line with expectations. reported revenue in dkk grew 6% and included negative impact from the divestment of skin care and currencies.
2025-02-04 07:12:00 Coloplast A/s - Allocation Of Share Options
Report on transactions of executives and related parties in coloplast shares and related securities according to the market abuse regulation article 19 coloplast is obliged to report on the transactions of executives and their related parties in coloplast shares and related securities. the below transactions concern allocation of share options.
2025-01-21 09:08:00 Coloplast A/s - Q1 2024/25 Earnings Release - Invitation To Conference Call On 4 February 2025 At 11.00am Cet
Tuesday, 4 february 2025 at 10.00 - 11.00am cet in connection with the publication of coloplast’s interim financial results for q1 2024/25, to be released same day around 07.30am cet, coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. a presentation will be available on coloplast’s website approximately 1 hour before the conference call.the webcast of the conference call will be available during and after the event.
2024-12-11 09:54:00 Coloplast A/s - Trading In Coloplast Shares By Board Members, Executives Or Associated Persons
Coloplast a/s - trading in coloplast shares by board members, executives or associated persons.
2024-12-05 11:11:00 Coloplast A/s - Decisions At The Annual General Meeting 2024
Today, 5 december 2024, coloplast a/s held its annual general meeting, at which the following resolutions were adopted: the annual report for the financial year 2023/24 was approved. distribution of year-end dividend of dkk 17.00 per share of nominally dkk 1 was approved.

What Our Users Say

"Before InsightfulValue, I used to manage due diligence in Excel and Word, which was time-consuming and prone to errors. Now, I have everything I need in one place, and it's all presented clearly and efficiently. It’s saved me hours each week and allowed me to focus on making smarter investment decisions."

John N.

Investment Manager

"I used to spend days pulling data from various sources and trying to make sense of it in spreadsheets. InsightfulValue has completely transformed my research process. The platform organizes everything for me in an easy-to-digest format, helping me make quick, informed decisions. It’s a game-changer for anyone serious about investing."

Samantha K.

Private Investor

"As a private investor, I used to rely on a mix of online reports and personal notes, which made due diligence feel like a guessing game. With InsightfulValue, I now have access to organized, professional-grade research that simplifies my decision-making process. It’s not only saved me time but also given me more confidence in my investment choices."

Daniel M.

Private Investor

"I used to get overwhelmed with the sheer volume of data when evaluating potential investments. InsightfulValue puts everything in one place, clearly laid out and easy to navigate. It's given me the tools I need to make smarter, quicker decisions, and it’s been an invaluable resource in growing my portfolio."

Rachel W.

Private Investor

"In the past, I relied on manually combining reports from multiple platforms, which took far too long and left room for mistakes. InsightfulValue streamlined the entire due diligence process, offering comprehensive insights in a few clicks. I can now focus more on strategy and less on data gathering, which has made my work far more efficient."

Mark T.

Financial Advisor

"Tracking and analyzing companies used to mean hours of sorting through spreadsheets, PDFs, and market reports. With InsightfulValue, I can easily access structured, high-quality data all in one place. It’s incredibly accurate and saves me a lot of time — time I can now use to optimize my portfolio."

Lisa P.

Portfolio Manager

"Before I found InsightfulValue, my team spent hours compiling data from various reports and sources, which often resulted in missing key insights. Now, we get clear, structured due diligence reports that save us time and reduce errors. It's made our investment analysis more precise and effective, and I can’t imagine going back to the old way."

David L.

Senior Analyst

"What really sets InsightfulValue apart is the quality of the companies in their database. Every company I've researched is backed by accurate, up-to-date data, making it easier to identify strong investment opportunities. The platform helps me focus on high-quality companies, reducing the time spent filtering through unreliable or outdated information."

James T.

Private Investor
© 2024 - 2025 InsightfulValue.com. All rights reserved. Legal